Aristeia Capital’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-23,582
| Closed | -$815K | – | 490 |
|
|
2025
Q1 | $815K | Sell |
23,582
-388,345
| -94% | -$13.4M | 0.02% | 142 |
|
|
2024
Q4 | $11.3M | Buy |
411,927
+275,340
| +202% | +$7.56M | 0.37% | 36 |
|
|
2024
Q3 | $3.48M | Buy |
136,587
+60,365
| +79% | +$1.54M | 0.07% | 93 |
|
|
2024
Q2 | $1.93M | Buy |
+76,222
| New | +$1.93M | 0.04% | 87 |
|
|
2023
Q1 | – | Sell |
-195,711
| Closed | -$1.49M | – | 382 |
|
|
2022
Q4 | $1.49M | Buy |
195,711
+45,711
| +30% | +$348K | 0.03% | 303 |
|
|
2022
Q3 | $1.49M | Sell |
150,000
-400,000
| -73% | -$3.98M | 0.03% | 383 |
|
|
2022
Q2 | $4.99M | Buy |
550,000
+502,100
| +1,048% | +$4.56M | 0.09% | 268 |
|
|
2022
Q1 | $486K | Buy |
+47,900
| New | +$486K | 0.01% | 396 |
|